93 related articles for article (PubMed ID: 21628920)
1. Synthesis of N-(trifluoromethyl-2-pyridinyl)arenesulfonamides as an inhibitor of secretory phospholipase A₂.
Nakayama H; Morita Y; Kimura H; Ishihara K; Akiba S; Uenishi J
Chem Pharm Bull (Tokyo); 2011; 59(6):783-6. PubMed ID: 21628920
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of N-[2-(2,4-Difluorophenoxy)trifluoromethyl-3-pyridyl]sulfonamides and their inhibitory activities against secretory phospholipase A₂.
Nakayama H; Ishihara K; Akiba S; Uenishi J
Chem Pharm Bull (Tokyo); 2011; 59(8):1069-72. PubMed ID: 21804258
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of secreted phospholipases A₂ by 2-oxoamides based on α-amino acids: Synthesis, in vitro evaluation and molecular docking calculations.
Mouchlis VD; Magrioti V; Barbayianni E; Cermak N; Oslund RC; Mavromoustakos TM; Gelb MH; Kokotos G
Bioorg Med Chem; 2011 Jan; 19(2):735-43. PubMed ID: 21216150
[TBL] [Abstract][Full Text] [Related]
4. Design of new potent and selective secretory phospholipase A2 inhibitors. Part 5: synthesis and biological activity of 1-alkyl-4-[4,5-dihydro-1,2,4-[4H]-oxadiazol-5-one-3-ylmethylbenz-4'-yl(oyl)] piperazines.
Boukli L; Touaibia M; Meddad-Belhabich N; Djimdé A; Park CH; Kim JJ; Yoon JH; Lamouri A; Heymans F
Bioorg Med Chem; 2008 Feb; 16(3):1242-53. PubMed ID: 17993277
[TBL] [Abstract][Full Text] [Related]
5. 2-Oxoamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudodipeptides.
Barbayianni E; Stephens D; Grkovich A; Magrioti V; Hsu YH; Dolatzas P; Kalogiannidis D; Dennis EA; Kokotos G
Bioorg Med Chem; 2009 Jul; 17(13):4833-43. PubMed ID: 19443224
[TBL] [Abstract][Full Text] [Related]
6. Highly specific and broadly potent inhibitors of mammalian secreted phospholipases A2.
Oslund RC; Cermak N; Gelb MH
J Med Chem; 2008 Aug; 51(15):4708-14. PubMed ID: 18605714
[TBL] [Abstract][Full Text] [Related]
7. New quinoxalinone inhibitors targeting secreted phospholipase A2 and α-glucosidase.
Alasmary FAS; Alnahdi FS; Ben Bacha A; El-Araby AM; Moubayed N; Alafeefy AM; El-Araby ME
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1143-1151. PubMed ID: 28856929
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and acrosin inhibitory activity of substituted 4-amino-N-(diaminomethylene) benzenesulfonamide derivatives.
Ding L; Zhu J; Zheng C; Sheng C; Qi J; Liu X; Han G; Zhao J; Lv J; Zhou Y
Bioorg Med Chem Lett; 2011 Nov; 21(22):6674-7. PubMed ID: 21983437
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships of natural and non-natural amino acid-based amide and 2-oxoamide inhibitors of human phospholipase A(2) enzymes.
Antonopoulou G; Barbayianni E; Magrioti V; Cotton N; Stephens D; Constantinou-Kokotou V; Dennis EA; Kokotos G
Bioorg Med Chem; 2008 Dec; 16(24):10257-69. PubMed ID: 18993078
[TBL] [Abstract][Full Text] [Related]
10. Varespladib inhibits secretory phospholipase A2 in bronchoalveolar lavage of different types of neonatal lung injury.
De Luca D; Minucci A; Trias J; Tripodi D; Conti G; Zuppi C; Capoluongo E;
J Clin Pharmacol; 2012 May; 52(5):729-37. PubMed ID: 21602519
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of the first inhibitor of N-acylphosphatidylethanolamine phospholipase D (NAPE-PLD).
Castellani B; Diamanti E; Pizzirani D; Tardia P; Maccesi M; Realini N; Magotti P; Garau G; Bakkum T; Rivara S; Mor M; Piomelli D
Chem Commun (Camb); 2017 Nov; 53(95):12814-12817. PubMed ID: 29143042
[TBL] [Abstract][Full Text] [Related]
12. Molecular modeling of the additional inhibitor site located in secretory phospholipase A(2).
Ompraba G; Velmurugan D; Louis PA; Rafi ZA
J Biomol Struct Dyn; 2010 Feb; 27(4):489-500. PubMed ID: 19916570
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationship studies of the amide functionality in (p-O-sulfamoyl)-N-alkanoyl tyramines as estrone sulfatase inhibitors.
Chu GH; Milano S; Kluth L; Rhodes M; Boni R; Johnson DA; Li PK
Steroids; 1997 Jul; 62(7):530-5. PubMed ID: 9253792
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of new secretory phospholipase A2 inhibitor of a phospholipid analog.
Iwama S; Segawa M; Fujii S; Ikeda K; Katsumura S
Bioorg Med Chem Lett; 1998 Dec; 8(24):3495-8. PubMed ID: 9934459
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of inhibition of human secretory phospholipase A2 by flavonoids: rationale for lead design.
Lättig J; Böhl M; Fischer P; Tischer S; Tietböhl C; Menschikowski M; Gutzeit HO; Metz P; Pisabarro MT
J Comput Aided Mol Des; 2007 Aug; 21(8):473-83. PubMed ID: 17701137
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel secretory phospholipase A2 inhibitors using virtual screen.
Qiu S; Chen F; Liu Y; Lai L
Chem Biol Drug Des; 2014 Aug; 84(2):216-22. PubMed ID: 24612767
[TBL] [Abstract][Full Text] [Related]
17. Novel pyridinyl and pyrimidinylcarbazole sulfonamides as antiproliferative agents.
Hu L; Li ZR; Wang YM; Wu Y; Jiang JD; Boykin DW
Bioorg Med Chem Lett; 2007 Mar; 17(5):1193-6. PubMed ID: 17197178
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of pro-inflammatory secreted phospholipase A2 by extracts from Cynara cardunculus L.
Kammoun M; Koubaa I; Ben Ali Y; Jarraya R; Gargouri Y; Damak M; Bezzine S
Appl Biochem Biotechnol; 2010 Oct; 162(3):662-70. PubMed ID: 19924387
[TBL] [Abstract][Full Text] [Related]
19. Reductions of phospholipase A(2) inhibition of pulmonary surfactant with hyaluronan.
Iwanicki JL; Lu KW; Taeusch HW
Exp Lung Res; 2010 Apr; 36(3):167-74. PubMed ID: 20334607
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in silico studies of novel sulfonamides having oxadiazole ring: As β-glucuronidase inhibitors.
Taha M; Baharudin MS; Ismail NH; Selvaraj M; Salar U; Alkadi KA; Khan KM
Bioorg Chem; 2017 Apr; 71():86-96. PubMed ID: 28160943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
